TrivarX Limited has appointed Dr Danielle Meyrick as Chief Executive Officer effective 1 June 2026. This appointment is part of the company's strategy to enhance its clinical and regulatory leadership as it progresses its Stabl-Im stable isotope-enhanced MRI platform.
Company Information
Company
TrivarX
Location
Australia
About
TrivarX is focused on developing advanced diagnostic technologies in the healthcare sector. The company aims to improve the accuracy and effectiveness of medical diagnostics. Its innovations target high-growth markets within neurology and oncology. The acquisition of Stabl-Im aligns with its strategic goals.